203 related articles for article (PubMed ID: 20659507)
1. Certainties, doubts and hypotheses in porcine reproductive and respiratory syndrome virus immunobiology.
Darwich L; Díaz I; Mateu E
Virus Res; 2010 Dec; 154(1-2):123-32. PubMed ID: 20659507
[TBL] [Abstract][Full Text] [Related]
2. Challenges for porcine reproductive and respiratory syndrome virus (PRRSV) vaccinology.
Kimman TG; Cornelissen LA; Moormann RJ; Rebel JM; Stockhofe-Zurwieden N
Vaccine; 2009 Jun; 27(28):3704-18. PubMed ID: 19464553
[TBL] [Abstract][Full Text] [Related]
3. Role of neutralizing antibodies in PRRSV protective immunity.
Lopez OJ; Osorio FA
Vet Immunol Immunopathol; 2004 Dec; 102(3):155-63. PubMed ID: 15507302
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of protective immunity in gilts inoculated with the NADC-8 isolate of porcine reproductive and respiratory syndrome virus (PRRSV) and challenge-exposed with an antigenically distinct PRRSV isolate.
Lager KM; Mengeling WL; Brockmeier SL
Am J Vet Res; 1999 Aug; 60(8):1022-7. PubMed ID: 10451216
[TBL] [Abstract][Full Text] [Related]
5. Adjuvants for porcine reproductive and respiratory syndrome virus vaccines.
Charerntantanakul W
Vet Immunol Immunopathol; 2009 May; 129(1-2):1-13. PubMed ID: 19157569
[TBL] [Abstract][Full Text] [Related]
6. Plasmid containing CpG oligodeoxynucleotides can augment the immune responses of pigs immunized with porcine reproductive and respiratory syndrome killed virus vaccine.
Quan Z; Qin ZG; Zhen W; Feng XZ; Hong J; Fei ZH
Vet Immunol Immunopathol; 2010 Aug; 136(3-4):257-64. PubMed ID: 20394988
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-12 (IL-12) ameliorates the effects of porcine respiratory and reproductive syndrome virus (PRRSV) infection.
Carter QL; Curiel RE
Vet Immunol Immunopathol; 2005 Aug; 107(1-2):105-18. PubMed ID: 15936827
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs naturally exposed to a heterologous European (Italian cluster) field strain: Clinical protection and cell-mediated immunity.
Martelli P; Gozio S; Ferrari L; Rosina S; De Angelis E; Quintavalla C; Bottarelli E; Borghetti P
Vaccine; 2009 Jun; 27(28):3788-99. PubMed ID: 19442420
[TBL] [Abstract][Full Text] [Related]
9. GM-CSF fused with GP3 and GP5 of porcine reproductive and respiratory syndrome virus increased the immune responses and protective efficacy against virulent PRRSV challenge.
Wang X; Li J; Jiang P; Li Y; Zeshan B; Cao J; Wang X
Virus Res; 2009 Jul; 143(1):24-32. PubMed ID: 19463718
[TBL] [Abstract][Full Text] [Related]
10. Interaction between innate immunity and porcine reproductive and respiratory syndrome virus.
Sang Y; Rowland RR; Blecha F
Anim Health Res Rev; 2011 Dec; 12(2):149-67. PubMed ID: 22152291
[TBL] [Abstract][Full Text] [Related]
11. Taming PRRSV: revisiting the control strategies and vaccine design.
Thanawongnuwech R; Suradhat S
Virus Res; 2010 Dec; 154(1-2):133-40. PubMed ID: 20851723
[TBL] [Abstract][Full Text] [Related]
12. Changes in peripheral blood leukocyte subpopulations in piglets co-infected experimentally with porcine reproductive and respiratory syndrome virus and porcine circovirus type 2.
Shi K; Li H; Guo X; Ge X; Jia H; Zheng S; Yang H
Vet Microbiol; 2008 Jun; 129(3-4):367-77. PubMed ID: 18164875
[TBL] [Abstract][Full Text] [Related]
13. Protection against porcine reproductive and respiratory syndrome virus (PRRSV) infection through passive transfer of PRRSV-neutralizing antibodies is dose dependent.
Lopez OJ; Oliveira MF; Garcia EA; Kwon BJ; Doster A; Osorio FA
Clin Vaccine Immunol; 2007 Mar; 14(3):269-75. PubMed ID: 17215336
[TBL] [Abstract][Full Text] [Related]
14. Immune response against porcine reproductive and respiratory syndrome virus during acute and chronic infection.
Molina RM; Cha SH; Chittick W; Lawson S; Murtaugh MP; Nelson EA; Christopher-Hennings J; Yoon KJ; Evans R; Rowland RR; Wu W-; Zimmerman JJ
Vet Immunol Immunopathol; 2008 Dec; 126(3-4):283-92. PubMed ID: 18835044
[TBL] [Abstract][Full Text] [Related]
15. Non-structural protein 2 of the porcine reproductive and respiratory syndrome (PRRS) virus: a crucial protein in viral pathogenesis, immunity and diagnosis.
Wang FX; Song N; Chen LZ; Cheng SP; Wu H; Wen YJ
Res Vet Sci; 2013 Aug; 95(1):1-7. PubMed ID: 23591056
[TBL] [Abstract][Full Text] [Related]
16. Immunological solutions for treatment and prevention of porcine reproductive and respiratory syndrome (PRRS).
Murtaugh MP; Genzow M
Vaccine; 2011 Oct; 29(46):8192-204. PubMed ID: 21925560
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity and protective efficacy of recombinant pseudorabies virus expressing the two major membrane-associated proteins of porcine reproductive and respiratory syndrome virus.
Jiang Y; Fang L; Xiao S; Zhang H; Pan Y; Luo R; Li B; Chen H
Vaccine; 2007 Jan; 25(3):547-60. PubMed ID: 16920232
[TBL] [Abstract][Full Text] [Related]
18. Negative impact of porcine reproductive and respiratory syndrome virus infection on the efficacy of classical swine fever vaccine.
Suradhat S; Kesdangsakonwut S; Sada W; Buranapraditkun S; Wongsawang S; Thanawongnuwech R
Vaccine; 2006 Mar; 24(14):2634-42. PubMed ID: 16406169
[TBL] [Abstract][Full Text] [Related]
19. Protective immunity induced by a recombinant pseudorabies virus expressing the GP5 of porcine reproductive and respiratory syndrome virus in piglets.
Qiu HJ; Tian ZJ; Tong GZ; Zhou YJ; Ni JQ; Luo YZ; Cai XH
Vet Immunol Immunopathol; 2005 Jul; 106(3-4):309-19. PubMed ID: 15963827
[TBL] [Abstract][Full Text] [Related]
20. CD40 ligand expressed in adenovirus can improve the immunogenicity of the GP3 and GP5 of porcine reproductive and respiratory syndrome virus in swine.
Cao J; Wang X; Du Y; Li Y; Wang X; Jiang P
Vaccine; 2010 Nov; 28(47):7514-22. PubMed ID: 20851084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
